ABSTRACT

Clinical practise, public health campaigns, and drug regulatory systems all employ pharmacovigilance to track and analyse adverse drug responses. Pharmacovigilance requires high expertise to swiftly identify prescription dangers and defend the medicine from inappropriate removal (ADRs). Uppsala Monitoring Centre's global pharmacovigilance system needs objective review. This would consider drug safety risks that threaten global public health. Pharmacovigilance identifies and understands previously unknown adverse drug responses. Pharmacovigilance is becoming more significant in clinical trials around the world. With the new millennium comes challenge in pharmacovigilance's pursuit of enhanced safety and monitoring. Pharmacovigilance centres monitor drug safety. This introduction covers medication safety, international pharmacovigilance centres, pharmacovigilance's pros and downsides, and future healthcare uses. In this article we have explained about the purpose of good safety communication for good pharmacovigilance practice and the way it can be performed. Alternately we get to know the means of communication and their purposes and the role of DHCP. Keywords: safety communication, DHCP, target audience
Publication date: 01/10/2023

https://ijbpas.com/pdf/2023/October/MS_IJBPAS_2023_7489.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.10.7489